Clinical Research Directory
Browse clinical research sites, groups, and studies.
Heparin Alone vs. Heparin-Aspirin Combo in Free Flap Survival
Sponsor: Aga Khan University
Summary
This randomized clinical trial aims to compare the effectiveness of heparin alone versus combination therapy of Heparin- Aspirin in improving free flap survival in patients undergoing reconstructive surgery. Participants will be randomly assigned to receive either heparin or a combination therapy, and the primary outcome measure will be the survival rate of the free flap at various time points post-surgery
Official title: Dual Therapy Dilemma: Heparin Alone vs. Heparin-Aspirin Combo in Free Flap Survival
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
126
Start Date
2025-01
Completion Date
2025-12
Last Updated
2024-07-23
Healthy Volunteers
Yes
Conditions
Interventions
LMW Heparin 5000 U/ML-Aspirin 75 MG
Arm 1
LMW Heparin 5000 U/ML
Arm 2
Locations (1)
Aga Khan University
Karachi, Sindh, Pakistan